Company / Gross Margin
Veracyte, Inc. Gross Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
70.1%
FY2025
5-year range
59.2% / 70.1%
FY2022-FY2025
Trend
+4.8%
vs FY2024
Sector context
#18 of 91
Health Care
What the data says
Veracyte, Inc.'s gross margin of 70.1% is higher than 80% of companies in the Health Care sector (FY2025). Gross Margin has increased for 3 consecutive years, from 59.2% in FY2022 to 70.1% in FY2025.
Based on SEC 10-K filings.
70.1% in FY2025 with a 3-year CAGR of +10.9%. Top quartile in the Health Care sector.
Improved from 63.6% to 70.1% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +10.9pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Top 20% in Health CareTop 20% of 91This company 70.1% Sector average 53.8%
▼
+30.3% above sector average
Key checks
Key Insights
- Veracyte, Inc.'s gross margin has grown for 3 consecutive years.
- In FY2025, gross margin increased 4.8% year-over-year.
- Currently 16.3pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 70.1% | +4.8% |
| FY2024 | 66.9% | +5.1% |
| FY2023 | 63.6% | +7.4% |
| FY2022 | 59.2% | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026